Bill > SB614

This bill allows pharmacists in West Virginia to provide Ivermectin to patients through two main pathways: first, via a collaborative pharmacy practice agreement that permits dispensing through non-patient-specific prescriptive orders, and second, by enabling over-the-counter sales once the FDA approves Ivermectin for such distribution. When Ivermectin becomes FDA-approved for over-the-counter use, pharmacists can sell it without requiring a prescription, with the only requirement being that they provide the patient with the FDA-approved information sheet. The bill also provides legal protections for pharmacists, ensuring they cannot be held liable in civil, criminal, or professional disciplinary proceedings if they dispense Ivermectin in good faith and in accordance with professional standards. Similarly, healthcare providers are protected from disciplinary actions by licensing boards for prescribing or recommending Ivermectin within their professional scope. The West Virginia Board of Pharmacy is authorized to establish rules for implementing these provisions, with most sections becoming effective 90 days after passage, and the over-the-counter sales provision taking effect immediately upon FDA approval. A severability clause ensures that if any part of the bill is found invalid, the remaining provisions will still stand.

Health and Social Services, Justice

http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=614&year=2025&sessiontype=RS&btype=bill